TRPM2 in the Brain: Role in Health and Disease
Abstract
:1. Introduction
2. TRPM2 inside the Brain
3. TRPM2 outside the Brain
4. Role of TRPM2 in Brain Diseases
4.1. Chronic Neurodegenerative Diseases
4.2. Acute Neurodegenerative Diseases
5. Future Perspectives
Funding
Acknowledgments
Conflicts of Interest
References
- Wu, L.-J.; Sweet, T.-B.; Clapham, D.E. International Union of Basic and Clinical Pharmacology. LXXVI. Current Progress in the Mammalian TRP Ion Channel Family. Pharmacol. Rev. 2010, 62, 381–404. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gaudet, R. Divide and conquer: High resolution structural information on TRP channel fragments. J. Gen. Physiol. 2009, 133, 231–237. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nilius, B.; Szallasi, A. Transient Receptor Potential Channels as Drug Targets: From the Science of Basic Research to the Art of Medicine. Pharmacol. Rev. 2014, 66, 676–814. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gees, M.; Colsoul, B.; Nilius, B. The role of transient receptor potential cation channels in Ca2+ signaling. Cold Spring Harb. Perspect. Biol. 2010, 2, a003962. [Google Scholar] [CrossRef] [PubMed]
- Nieto-Posadas, A.; Jara-Oseguera, A.; Rosenbaum, T. TRP channel gating physiology. Curr. Top. Med. Chem. 2011, 11, 2131–2150. [Google Scholar] [CrossRef] [PubMed]
- Jara-Oseguera, A.; Islas, L.D. The role of allosteric coupling on thermal activation of thermo-TRP channels. Biophys. J. 2013, 104, 2160–2169. [Google Scholar] [CrossRef] [PubMed]
- Ramsey, I.S.; Delling, M.; Clapham, D.E. An introduction to TRP channels. Annu. Rev. Physiol. 2006, 68, 619–647. [Google Scholar] [CrossRef] [PubMed]
- Clapham, D.E. Calcium signaling. Cell 1995, 80, 259–268. [Google Scholar] [CrossRef]
- Clapham, D.E.; Montell, C.; Schultz, G.; Julius, D. International Union of Pharmacology. XLIII. Compendium of voltage-gated ion channels: Transient receptor potential channels. Pharmacol. Rev. 2003, 55, 591–596. [Google Scholar] [CrossRef] [PubMed]
- Clapham, D.E. TRP channels as cellular sensors. Nature 2003, 426, 517–524. [Google Scholar] [CrossRef] [PubMed]
- Aarts, M.M.; Tymianski, M. TRPMs and neuronal cell death. Pflugers Arch. Eur. J. Physiol. 2005, 451, 243–249. [Google Scholar] [CrossRef] [PubMed]
- Arundine, M.; Tymianski, M. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 2003, 34, 325–337. [Google Scholar] [CrossRef]
- Choi, D.W. Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage. Trends Neurosci. 1988, 11, 465–469. [Google Scholar] [CrossRef]
- Vriens, J.; Watanabe, H.; Janssens, A.; Droogmans, G.; Voets, T.; Nilius, B. Cell swelling, heat, and chemical agonists use distinct pathways for the activation of the cation channel TRPV4. Proc. Natl. Acad. Sci. USA 2004, 101, 396–401. [Google Scholar] [CrossRef] [PubMed]
- Sawamura, S.; Shirakawa, H.; Nakagawa, T.; Mori, Y.; Kaneko, S. TRP Channels in the Brain: What Are They There For? In Neurobiology of TRP Channels; CRC Press/Taylor & Francis: Boca Raton, FL, USA, 2017; ISBN 9781315152837. [Google Scholar]
- Grigoryan, G.; Keating, A.E. Structural specificity in coiled-coil interactions. Curr. Opin. Struct. Biol. 2008, 18, 477–483. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fonfria, E.; Murdock, P.R.; Cusdin, F.S.; Benham, C.D.; Kelsell, R.E.; McNulty, S. Tissue distribution profiles of the human TRPM cation channel family. J. Recept. Signal Transduct. Res. 2006, 26, 159–178. [Google Scholar] [CrossRef] [PubMed]
- Nagamine, K.; Kudoh, J.; Minoshima, S.; Kawasaki, K.; Asakawa, S.; Ito, F.; Shimizu, N. Molecular cloning of a novel putative Ca2+ channel protein (TRPC7) highly expressed in brain. Genomics 1998, 54, 124–131. [Google Scholar] [CrossRef] [PubMed]
- Xia, R.; Mei, Z.-Z.; Mao, H.-J.; Yang, W.; Dong, L.; Bradley, H.; Beech, D.J.; Jiang, L.-H. Identification of pore residues engaged in determining divalent cationic permeation in transient receptor potential melastatin subtype channel 2. J. Biol. Chem. 2008, 283, 27426–27432. [Google Scholar] [CrossRef] [PubMed]
- Belrose, J.C.; Jackson, M.F. TRPM2: A candidate therapeutic target for treating neurological diseases. Acta Pharmacol. Sin. 2018, 39, 722–735. [Google Scholar] [CrossRef] [PubMed]
- Yue, Z.; Xie, J.; Yu, A.S.; Stock, J.; Du, J.; Yue, L. Role of TRP channels in the cardiovascular system. Am. J. Physiol. Circ. Physiol. 2015, 308, H157–H182. [Google Scholar] [CrossRef] [PubMed]
- Kheradpezhouh, E.; Ma, L.; Morphett, A.; Barritt, G.J.; Rychkov, G.Y. TRPM2 channels mediate acetaminophen-induced liver damage. Proc. Natl. Acad. Sci. USA 2014, 111, 3176–3181. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhang, Z.; Tóth, B.; Szollosi, A.; Chen, J.; Csanády, L. Structure of a TRPM2 channel in complex with Ca2+ explains unique gating regulation. Elife 2018, 7. [Google Scholar] [CrossRef] [PubMed]
- Turlova, E.; Feng, Z.; Sun, H. The role of TRPM2 channels in neurons, glial cells and the blood-brain barrier in cerebral ischemia and hypoxia. Acta Pharmacol. Sin. 2018, 39, 713–721. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wehage, E.; Eisfeld, J.; Heiner, I.; Jüngling, E.; Zitt, C.; Lückhoff, A. Activation of the cation channel long transient receptor potential channel 2 (LTRPC2) by hydrogen peroxide. A splice variant reveals a mode of activation independent of ADP-ribose. J. Biol. Chem. 2002, 277, 23150–23156. [Google Scholar] [CrossRef] [PubMed]
- McHugh, D.; Flemming, R.; Xu, S.-Z.; Perraud, A.-L.; Beech, D.J. Critical intracellular Ca2+ dependence of transient receptor potential melastatin 2 (TRPM2) cation channel activation. J. Biol. Chem. 2003, 278, 11002–11006. [Google Scholar] [CrossRef] [PubMed]
- Perraud, A.L.; Fleig, A.; Dunn, C.A.; Bagley, L.A.; Launay, P.; Schmitz, C.; Stokes, A.J.; Zhu, Q.; Bessman, M.J.; Penner, R.; et al. ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology. Nature 2001, 411, 595–599. [Google Scholar] [CrossRef] [PubMed]
- Fliegert, R.; Bauche, A.; Wolf Pérez, A.-M.; Watt, J.M.; Rozewitz, M.D.; Winzer, R.; Janus, M.; Gu, F.; Rosche, A.; Harneit, A.; et al. 2′-Deoxyadenosine 5′-diphosphoribose is an endogenous TRPM2 superagonist. Nat. Chem. Biol. 2017, 13, 1036–1044. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Harteneck, C. Function and pharmacology of TRPM cation channels. Naunyn Schmiedebergs Arch. Pharmacol. 2005, 371, 307–314. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fonfria, E.; Marshall, I.C.B.; Benham, C.D.; Boyfield, I.; Brown, J.D.; Hill, K.; Hughes, J.P.; Skaper, S.D.; McNulty, S. TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP-ribose) polymerase. Br. J. Pharmacol. 2004, 143, 186–192. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Olah, M.E.; Jackson, M.F.; Li, H.; Perez, Y.; Sun, H.-S.; Kiyonaka, S.; Mori, Y.; Tymianski, M.; MacDonald, J.F. Ca2+-dependent induction of TRPM2 currents in hippocampal neurons. J. Physiol. 2009, 587, 965–979. [Google Scholar] [CrossRef] [PubMed]
- Xie, Y.-F.; Belrose, J.C.; Lei, G.; Tymianski, M.; Mori, Y.; MacDonald, J.F.; Jackson, M.F. Dependence of NMDA/GSK-3β Mediated Metaplasticity on TRPM2 Channels at Hippocampal CA3-CA1 Synapses. Mol. Brain 2011, 4, 44. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jang, Y.; Lee, M.H.; Lee, J.; Jung, J.; Lee, S.H.; Yang, D.-J.; Kim, B.W.; Son, H.; Lee, B.; Chang, S.; et al. TRPM2 mediates the lysophosphatidic acid-induced neurite retraction in the developing brain. Pflügers Arch. Eur. J. Physiol. 2014, 466, 1987–1998. [Google Scholar] [CrossRef] [PubMed]
- Yamamoto, S.; Shimizu, S.; Kiyonaka, S.; Takahashi, N.; Wajima, T.; Hara, Y.; Negoro, T.; Hiroi, T.; Kiuchi, Y.; Okada, T.; et al. TRPM2-mediated Ca2+ influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration. Nat. Med. 2008, 14, 738–747. [Google Scholar] [CrossRef] [PubMed]
- Haraguchi, K.; Kawamoto, A.; Isami, K.; Maeda, S.; Kusano, A.; Asakura, K.; Shirakawa, H.; Mori, Y.; Nakagawa, T.; Kaneko, S. TRPM2 contributes to inflammatory and neuropathic pain through the aggravation of pronociceptive inflammatory responses in mice. J. Neurosci. 2012, 32, 3931–3941. [Google Scholar] [CrossRef] [PubMed]
- Kraft, R.; Grimm, C.; Grosse, K.; Hoffmann, A.; Sauerbruch, S.; Kettenmann, H.; Schultz, G.; Harteneck, C. Hydrogen peroxide and ADP-ribose induce TRPM2-mediated calcium influx and cation currents in microglia. Am. J. Physiol. Cell Physiol. 2004, 286, C129–C137. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Miyake, T.; Shirakawa, H.; Kusano, A.; Sakimoto, S.; Konno, M.; Nakagawa, T.; Mori, Y.; Kaneko, S. TRPM2 contributes to LPS/IFNγ-induced production of nitric oxide via the p38/JNK pathway in microglia. Biochem. Biophys. Res. Commun. 2014, 444, 212–217. [Google Scholar] [CrossRef] [PubMed]
- Hiroi, T.; Wajima, T.; Negoro, T.; Ishii, M.; Nakano, Y.; Kiuchi, Y.; Mori, Y.; Shimizu, S. Neutrophil TRPM2 channels are implicated in the exacerbation of myocardial ischaemia/reperfusion injury. Cardiovasc. Res. 2013, 97, 271–281. [Google Scholar] [CrossRef] [PubMed]
- Tripathi, J.K.; Sharma, A.; Sukumaran, P.; Sun, Y.; Mishra, B.B.; Singh, B.B.; Sharma, J. Oxidant sensor cation channel TRPM2 regulates neutrophil extracellular trap formation and protects against pneumoseptic bacterial infection. FASEB J. 2018, fj.201800605. [Google Scholar] [CrossRef] [PubMed]
- Zou, J.; Ainscough, J.F.; Yang, W.; Sedo, A.; Yu, S.-P.; Mei, Z.-Z.; Sivaprasadarao, A.; Beech, D.J.; Jiang, L.-H. A differential role of macrophage TRPM2 channels in Ca2+ signaling and cell death in early responses to H2O2. Am. J. Physiol. Cell Physiol. 2013, 305, C61–C69. [Google Scholar] [CrossRef] [PubMed]
- Di, A.; Kiya, T.; Gong, H.; Gao, X.; Malik, A.B. Role of the phagosomal redox-sensitive TRP channel TRPM2 in regulating bactericidal activity of macrophages. J. Cell Sci. 2017, 130, 735–744. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Roedding, A.S.; Gao, A.F.; Au-Yeung, W.; Scarcelli, T.; Li, P.P.; Warsh, J.J. Effect of oxidative stress on TRPM2 and TRPC3 channels in B lymphoblast cells in bipolar disorder. Bipolar Disord. 2012, 14, 151–161. [Google Scholar] [CrossRef] [PubMed]
- Syed Mortadza, S.A.; Wang, L.; Li, D.; Jiang, L.-H. TRPM2 Channel-Mediated ROS-Sensitive Ca2+ Signaling Mechanisms in Immune Cells. Front. Immunol. 2015, 6, 407. [Google Scholar] [CrossRef] [PubMed]
- Wehrhahn, J.; Kraft, R.; Harteneck, C.; Hauschildt, S. Transient receptor potential melastatin 2 is required for lipopolysaccharide-induced cytokine production in human monocytes. J. Immunol. 2010, 184, 2386–2393. [Google Scholar] [CrossRef] [PubMed]
- Sumoza-Toledo, A.; Lange, I.; Cortado, H.; Bhagat, H.; Mori, Y.; Fleig, A.; Penner, R.; Partida-Sánchez, S. Dendritic cell maturation and chemotaxis is regulated by TRPM2-mediated lysosomal Ca2+ release. FASEB J. 2011, 25, 3529–3542. [Google Scholar] [CrossRef] [PubMed]
- Faouzi, M.; Penner, R. Mammalian Transient Receptor Potential (TRP) Cation Channels. In Handbook of Experimental Pharmacology; Springer-Verlag: Berlin/Heidelberg, Germany, 2014; Volume 222, ISBN 978-3-642-54214-5. [Google Scholar]
- Knowles, H.; Heizer, J.W.; Li, Y.; Chapman, K.; Ogden, C.A.; Andreasen, K.; Shapland, E.; Kucera, G.; Mogan, J.; Humann, J.; et al. Transient Receptor Potential Melastatin 2 (TRPM2) ion channel is required for innate immunity against Listeria monocytogenes. Proc. Natl. Acad. Sci. USA 2011, 108, 11578–11583. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Di, A.; Gao, X.-P.; Qian, F.; Kawamura, T.; Han, J.; Hecquet, C.; Ye, R.D.; Vogel, S.M.; Malik, A.B. The redox-sensitive cation channel TRPM2 modulates phagocyte ROS production and inflammation. Nat. Immunol. 2011, 13, 29–34. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kashio, M.; Sokabe, T.; Shintaku, K.; Uematsu, T.; Fukuta, N.; Kobayashi, N.; Mori, Y.; Tominaga, M. Redox signal-mediated sensitization of transient receptor potential melastatin 2 (TRPM2) to temperature affects macrophage functions. Proc. Natl. Acad. Sci. USA 2012, 109, 6745–6750. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Togashi, K.; Hara, Y.; Tominaga, T.; Higashi, T.; Konishi, Y.; Mori, Y.; Tominaga, M. TRPM2 activation by cyclic ADP-ribose at body temperature is involved in insulin secretion. EMBO J. 2006, 25, 1804–1815. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Uchida, K.; Dezaki, K.; Damdindorj, B.; Inada, H.; Shiuchi, T.; Mori, Y.; Yada, T.; Minokoshi, Y.; Tominaga, M. Lack of TRPM2 impaired insulin secretion and glucose metabolisms in mice. Diabetes 2011, 60, 119–126. [Google Scholar] [CrossRef] [PubMed]
- Pang, B.; Kim, S.; Li, D.; Ma, Z.; Sun, B.; Zhang, X.; Wu, Z.; Chen, L. Glucagon-like peptide-1 potentiates glucose-stimulated insulin secretion via the transient receptor potential melastatin 2 channel. Exp. Ther. Med. 2017, 14, 5219–5227. [Google Scholar] [CrossRef] [PubMed]
- Tan, C.-H.; McNaughton, P.A. The TRPM2 ion channel is required for sensitivity to warmth. Nature 2016, 536, 460–463. [Google Scholar] [CrossRef] [PubMed]
- Tan, C.-H.; McNaughton, P.A. TRPM2 and warmth sensation. Pflügers Arch. Eur. J. Physiol. 2018, 470, 787–798. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Song, K.; Wang, H.; Kamm, G.B.; Pohle, J.; de Castro Reis, F.; Heppenstall, P.; Wende, H.; Siemens, J. The TRPM2 channel is a hypothalamic heat sensor that limits fever and can drive hypothermia. Science 2016, 353, 1393–1398. [Google Scholar] [CrossRef] [PubMed]
- Kashio, M.; Tominaga, M. The TRPM2 channel: A thermo-sensitive metabolic sensor. Channels 2017, 11, 426–433. [Google Scholar] [CrossRef] [PubMed]
- Sun, L.; Yau, H.-Y.; Wong, W.-Y.; Li, R.A.; Huang, Y.; Yao, X. Role of TRPM2 in H(2)O(2)-induced cell apoptosis in endothelial cells. PLoS ONE 2012, 7, e43186. [Google Scholar] [CrossRef]
- Massullo, P.; Sumoza-Toledo, A.; Bhagat, H.; Partida-Sánchez, S. TRPM channels, calcium and redox sensors during innate immune responses. Semin. Cell Dev. Biol. 2006, 17, 654–666. [Google Scholar] [CrossRef] [PubMed]
- Barbosa, M.; Valentão, P.; Andrade, P.B. Bioactive compounds from macroalgae in the new millennium: Implications for neurodegenerative diseases. Mar. Drugs 2014, 12, 4934–4972. [Google Scholar] [CrossRef] [PubMed]
- Thibault, O.; Gant, J.C.; Landfield, P.W. Expansion of the calcium hypothesis of brain aging and Alzheimer’s disease: Minding the store. Aging Cell 2007, 6, 307–317. [Google Scholar] [CrossRef] [PubMed]
- Shimizu, T.; Dietz, R.M.; Cruz-Torres, I.; Strnad, F.; Garske, A.K.; Moreno, M.; Venna, V.R.; Quillinan, N.; Herson, P.S. Extended therapeutic window of a novel peptide inhibitor of TRPM2 channels following focal cerebral ischemia. Exp. Neurol. 2016, 283, 151–156. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Takahashi, N.; Kozai, D.; Kobayashi, R.; Ebert, M.; Mori, Y. Roles of TRPM2 in oxidative stress. Cell Calcium 2011, 50, 279–287. [Google Scholar] [CrossRef] [PubMed]
- Langley, B.; Ratan, R.R. Oxidative stress-induced death in the nervous system: Cell cycle dependent or independent? J. Neurosci. Res. 2004, 77, 621–629. [Google Scholar] [CrossRef] [PubMed]
- Chandra, J.; Samali, A.; Orrenius, S. Triggering and modulation of apoptosis by oxidative stress. Free Radic. Biol. Med. 2000, 29, 323–333. [Google Scholar] [CrossRef]
- Chung, W.-S.; Welsh, C.A.; Barres, B.A.; Stevens, B. Do glia drive synaptic and cognitive impairment in disease? Nat. Neurosci. 2015, 18, 1539–1545. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Urrutia, P.J.; Hirsch, E.C.; González-Billault, C.; Núñez, M.T. Hepcidin attenuates amyloid beta-induced inflammatory and pro-oxidant responses in astrocytes and microglia. J. Neurochem. 2017, 142, 140–152. [Google Scholar] [CrossRef] [PubMed]
- Daulatzai, M.A. Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer’s disease in focal cerebral ischemic rats. Am. J. Neurodegener. Dis. 2016, 5, 102–130. [Google Scholar] [PubMed]
- Mattson, M.P. Calcium and neurodegeneration. Aging Cell 2007, 6, 337–350. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nikoletopoulou, V.; Tavernarakis, N. Calcium homeostasis in aging neurons. Front. Genet. 2012, 3, 200. [Google Scholar] [CrossRef] [PubMed]
- Kregel, K.C.; Zhang, H.J. An integrated view of oxidative stress in aging: Basic mechanisms, functional effects, and pathological considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292, R18–R36. [Google Scholar] [CrossRef] [PubMed]
- Parihar, M.S.; Kunz, E.A.; Brewer, G.J. Age-related decreases in NAD(P)H and glutathione cause redox declines before ATP loss during glutamate treatment of hippocampal neurons. J. Neurosci. Res. 2008, 86, 2339–2352. [Google Scholar] [CrossRef] [PubMed]
- Cooper, A.J.; Kristal, B.S. Multiple roles of glutathione in the central nervous system. Biol. Chem. 1997, 378, 793–802. [Google Scholar] [PubMed]
- Belrose, J.C.; Xie, Y.-F.; Gierszewski, L.J.; MacDonald, J.F.; Jackson, M.F. Loss of glutathione homeostasis associated with neuronal senescence facilitates TRPM2 channel activation in cultured hippocampal pyramidal neurons. Mol. Brain 2012, 5, 11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Robillard, J.M.; Gordon, G.R.; Choi, H.B.; Christie, B.R.; MacVicar, B.A. Glutathione restores the mechanism of synaptic plasticity in aged mice to that of the adult. PLoS ONE 2011, 6, e20676. [Google Scholar] [CrossRef] [PubMed]
- Aoyama, K.; Suh, S.W.; Hamby, A.M.; Liu, J.; Chan, W.Y.; Chen, Y.; Swanson, R.A. Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat. Neurosci. 2006, 9, 119–126. [Google Scholar] [CrossRef] [PubMed]
- Norris, C.M.; Korol, D.L.; Foster, T.C. Increased susceptibility to induction of long-term depression and long-term potentiation reversal during aging. J. Neurosci. 1996, 16, 5382–5392. [Google Scholar] [CrossRef] [PubMed]
- Xie, Y.F.; MacDonald, J.F.; Jackson, M.F. TRPM2, calcium and neurodegenerative diseases. Int. J. Physiol. Pathophysiol. Pharmacol. 2010, 2, 95–103. [Google Scholar] [PubMed]
- Butterfield, D.; Drake, J.; Pocernich, C.; Castegna, A. Evidence of oxidative damage in Alzheimer’s disease brain: Central role for amyloid β-peptide. Trends Mol. Med. 2001, 7, 548–554. [Google Scholar] [CrossRef]
- Balaban, H.; Nazıroğlu, M.; Demirci, K.; Övey, İ.S. The Protective Role of Selenium on Scopolamine-Induced Memory Impairment, Oxidative Stress, and Apoptosis in Aged Rats: The Involvement of TRPM2 and TRPV1 Channels. Mol. Neurobiol. 2017, 54, 2852–2868. [Google Scholar] [CrossRef] [PubMed]
- Frozza, R.L.; Bernardi, A.; Hoppe, J.B.; Meneghetti, A.B.; Matté, A.; Battastini, A.M.O.; Pohlmann, A.R.; Guterres, S.S.; Salbego, C. Neuroprotective effects of resveratrol against Aβ administration in rats are improved by lipid-core nanocapsules. Mol. Neurobiol. 2013, 47, 1066–1080. [Google Scholar] [CrossRef] [PubMed]
- Morroni, F.; Sita, G.; Tarozzi, A.; Rimondini, R.; Hrelia, P. Early effects of Aβ1-42 oligomers injection in mice: Involvement of PI3K/Akt/GSK3 and MAPK/ERK1/2 pathways. Behav. Brain Res. 2016, 314, 106–115. [Google Scholar] [CrossRef] [PubMed]
- Jo, S.; Yarishkin, O.; Hwang, Y.J.; Chun, Y.E.; Park, M.; Woo, D.H.; Bae, J.Y.; Kim, T.; Lee, J.; Chun, H.; et al. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer’s disease. Nat. Med. 2014, 20, 886–896. [Google Scholar] [CrossRef] [PubMed]
- Pascale, A.; Etcheberrigaray, R. Calcium alterations in Alzheimer’s disease: Pathophysiology, models and therapeutic opportunities. Pharmacol. Res. 1999, 39, 81–88. [Google Scholar] [CrossRef] [PubMed]
- Kurz, A.F. Uncommon neurodegenerative causes of dementia. Int. Psychogeriatr. 2005, 17 (Suppl. 1), S35–S49. [Google Scholar] [CrossRef] [PubMed]
- Nishimura, I.; Takazaki, R.; Kuwako, K.I.; Enokido, Y.; Yoshikawa, K. Upregulation and antiapoptotic role of endogenous Alzheimer amyloid precursor protein in dorsal root ganglion neurons. Exp. Cell Res. 2003, 286, 241–251. [Google Scholar] [CrossRef]
- Nazıroğlu, M. TRPM2 cation channels, oxidative stress and neurological diseases: Where are we now? Neurochem. Res. 2011, 36, 355–366. [Google Scholar] [CrossRef] [PubMed]
- Saharan, S.; Mandal, P.K. The emerging role of glutathione in Alzheimer’s disease. J. Alzheimers Dis. 2014, 40, 519–529. [Google Scholar] [CrossRef] [PubMed]
- Lesuisse, C.; Martin, L.J. Long-term culture of mouse cortical neurons as a model for neuronal development, aging, and death. J. Neurobiol. 2002, 51, 9–23. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Övey, İ.S.; Naziroğlu, M. Homocysteine and cytosolic GSH depletion induce apoptosis and oxidative toxicity through cytosolic calcium overload in the hippocampus of aged mice: Involvement of TRPM2 and TRPV1 channels. Neuroscience 2015, 284, 225–233. [Google Scholar] [CrossRef] [PubMed]
- Wang, J.; Jackson, M.F.; Xie, Y.F. Glia and TRPM2 Channels in Plasticity of Central Nervous System and Alzheimer’s Diseases. Neural Plast. 2016, 2016, 16–18. [Google Scholar] [CrossRef] [PubMed]
- Fonfria, E.; Marshall, I.C.B.; Boyfield, I.; Skaper, S.D.; Hughes, J.P.; Owen, D.E.; Zhang, W.; Miller, B.A.; Benham, C.D.; McNulty, S. Amyloid beta-peptide(1-42) and hydrogen peroxide-induced toxicity are mediated by TRPM2 in rat primary striatal cultures. J. Neurochem. 2005, 95, 715–723. [Google Scholar] [CrossRef] [PubMed]
- Yankner, B.A.; Lu, T.; Loerch, P. The aging brain. Annu. Rev. Pathol. 2008, 3, 41–66. [Google Scholar] [CrossRef] [PubMed]
- Ostapchenko, V.G.; Chen, M.; Guzman, M.S.; Xie, Y.-F.; Lavine, N.; Fan, J.; Beraldo, F.H.; Martyn, A.C.; Belrose, J.C.; Mori, Y.; et al. The Transient Receptor Potential Melastatin 2 (TRPM2) Channel Contributes to -Amyloid Oligomer-Related Neurotoxicity and Memory Impairment. J. Neurosci. 2015, 35, 15157–15169. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Alawieyah Syed Mortadza, S.; Sim, J.A.; Neubrand, V.E.; Jiang, L.-H. A critical role of TRPM2 channel in Aβ42-induced microglial activation and generation of tumor necrosis factor-α. Glia 2018, 66, 562–575. [Google Scholar] [CrossRef] [PubMed]
- Park, L.; Wang, G.; Moore, J.; Girouard, H.; Zhou, P.; Anrather, J.; Iadecola, C. The key role of transient receptor potential melastatin-2 channels in amyloid-β-induced neurovascular dysfunction. Nat. Commun. 2014, 5, 5318. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Xu, C.; Macciardi, F.; Li, P.P.; Yoon, I.-S.; Cooke, R.G.; Hughes, B.; Parikh, S.V.; McIntyre, R.S.; Kennedy, J.L.; Warsh, J.J. Association of the putative susceptibility gene, transient receptor potential protein melastatin type 2, with bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141, 36–43. [Google Scholar] [CrossRef] [PubMed]
- McQuillin, A.; Bass, N.J.; Kalsi, G.; Lawrence, J.; Puri, V.; Choudhury, K.; Detera-Wadleigh, S.D.; Curtis, D.; Gurling, H.M.D. Fine mapping of a susceptibility locus for bipolar and genetically related unipolar affective disorders, to a region containing the C21ORF29 and TRPM2 genes on chromosome 21q22.3. Mol. Psychiatry 2006, 11, 134–142. [Google Scholar] [CrossRef] [PubMed]
- Hermosura, M.C.; Cui, A.M.; Go, R.C.V.; Davenport, B.; Shetler, C.M.; Heizer, J.W.; Schmitz, C.; Mocz, G.; Garruto, R.M.; Perraud, A.-L. Altered functional properties of a TRPM2 variant in Guamanian ALS and PD. Proc. Natl. Acad. Sci. USA 2008, 105, 18029–18034. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Olney, J.W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969, 164, 719–721. [Google Scholar] [CrossRef] [PubMed]
- Dugan, L.L.; Choi, D.W. Excitotoxicity, free radicals, and cell membrane changes. Ann. Neurol. 1994, 35, S17–S21. [Google Scholar] [CrossRef] [PubMed]
- MacDonald, J.F.; Xiong, Z.-G.; Jackson, M.F. Paradox of Ca2+ signaling, cell death and stroke. Trends Neurosci. 2006, 29, 75–81. [Google Scholar] [CrossRef] [PubMed]
- Fonfria, E.; Mattei, C.; Hill, K.; Brown, J.T.; Randall, A.; Benham, C.D.; Skaper, S.D.; Campbell, C.A.; Crook, B.; Murdock, P.R.; et al. TRPM2 is elevated in the tMCAO stroke model, transcriptionally regulated, and functionally expressed in C13 microglia. J. Recept. Signal Transduct. 2006, 26, 179–198. [Google Scholar] [CrossRef] [PubMed]
- Huang, S.; Turlova, E.; Li, F.; Bao, M.; Szeto, V.; Wong, R.; Abussaud, A.; Wang, H.; Zhu, S.; Gao, X.; et al. Transient receptor potential melastatin 2 channels (TRPM2) mediate neonatal hypoxic-ischemic brain injury in mice. Exp. Neurol. 2017, 296, 32–40. [Google Scholar] [CrossRef] [PubMed]
- Yamamoto, S.; Shimizu, S. Targeting TRPM2 in ROS-Coupled Diseases. Pharmaceuticals 2016, 9, 57. [Google Scholar] [CrossRef] [PubMed]
- Hara, Y.; Wakamori, M.; Ishii, M.; Maeno, E.; Nishida, M.; Yoshida, T.; Yamada, H.; Shimizu, S.; Mori, E.; Kudoh, J.; et al. LTRPC2 Ca2+-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol. Cell 2002, 9, 163–173. [Google Scholar] [CrossRef]
- Jia, J.; Verma, S.; Nakayama, S.; Quillinan, N.; Grafe, M.R.; Hurn, P.D.; Herson, P.S. Sex differences in neuroprotection provided by inhibition of TRPM2 channels following experimental stroke. J. Cereb. Blood Flow Metab. 2011, 31, 2160–2168. [Google Scholar] [CrossRef] [PubMed]
- Shimizu, K.; Quillinan, N.; Orfila, J.E.; Herson, P.S. Sirtuin-2 mediates male specific neuronal injury following experimental cardiac arrest through activation of TRPM2 ion channels. Exp. Neurol. 2016, 275, 78–83. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Romero, J.R.; Morris, J.; Pikula, A. Stroke prevention: Modifying risk factors. Ther. Adv. Cardiovasc. Dis. 2008, 2, 287–303. [Google Scholar] [CrossRef] [PubMed]
- Herson, P.S.; Traystman, R.J. Animal models of stroke: Translational potential at present and in 2050. Future Neurol. 2014, 9, 541–551. [Google Scholar] [CrossRef] [PubMed]
- Wigginton, J.G.; Pepe, P.E.; Bedolla, J.P.; DeTamble, L.A.; Atkins, J.M. Sex-related differences in the presentation and outcome of out-of-hospital cardiopulmonary arrest: A multiyear, prospective, population-based study. Crit. Care Med. 2002, 30, S131–S136. [Google Scholar] [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sita, G.; Hrelia, P.; Graziosi, A.; Ravegnini, G.; Morroni, F. TRPM2 in the Brain: Role in Health and Disease. Cells 2018, 7, 82. https://doi.org/10.3390/cells7070082
Sita G, Hrelia P, Graziosi A, Ravegnini G, Morroni F. TRPM2 in the Brain: Role in Health and Disease. Cells. 2018; 7(7):82. https://doi.org/10.3390/cells7070082
Chicago/Turabian StyleSita, Giulia, Patrizia Hrelia, Agnese Graziosi, Gloria Ravegnini, and Fabiana Morroni. 2018. "TRPM2 in the Brain: Role in Health and Disease" Cells 7, no. 7: 82. https://doi.org/10.3390/cells7070082